Get the Stockscreener App
4.53
1.74%
-0.08
After Hours:
4.44
-0.09
-1.99%
Sonoma Pharmaceuticals Inc stock is traded at $4.53, with a volume of 59,237.
It is down -1.74% in the last 24 hours and up +46.84% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$4.61
Open:
$4.51
24h Volume:
59,237
Relative Volume:
0.05
Market Cap:
$7.44M
Revenue:
$12.31M
Net Income/Loss:
$-5.08M
P/E Ratio:
-4.8191
EPS:
-0.94
Net Cash Flow:
$-5.20M
1W Performance:
-0.66%
1M Performance:
+46.84%
6M Performance:
+114.69%
1Y Performance:
+41.53%
1-Day Range:
$4.45
$4.5999
1-Week Range:
$4.39
$4.77
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
4.53 | 7.74M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
How moving averages guide Sonoma Pharmaceuticals Inc. tradingWeekly Gains Report & Smart Money Movement Tracker - Newser
What machine learning models say about Sonoma Pharmaceuticals IncJuly 2025 Reactions & Low Risk Entry Point Guides - Newser
Is this a good reentry point in Sonoma Pharmaceuticals Inc.Chart Signals & High Accuracy Swing Trade Signals - Newser
Is Sonoma Pharmaceuticals Inc. reversing from oversold territoryWeekly Stock Analysis & Weekly Top Gainers Trade List - Newser
What machine learning models say about Sonoma Pharmaceuticals Inc.Quarterly Market Review & Verified Technical Trade Signals - Newser
Will Sonoma Pharmaceuticals Inc. see short term momentum2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Is a relief rally coming for Sonoma Pharmaceuticals Inc. holders2025 Year in Review & Expert-Curated Trade Recommendations - Newser
Chart based exit strategy for Sonoma Pharmaceuticals Inc.Weekly Stock Recap & Stepwise Trade Signal Guides - Newser
Sonoma Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Pullbacks & Verified Chart Pattern Signals - Newser
Will Sonoma Pharmaceuticals Inc. stock recover after earningsTrade Risk Report & Accurate Intraday Trade Tips - khodrobank.com
Sonoma Pharmaceuticals Inc. stock chart pattern explainedPortfolio Growth Summary & Real-Time Stock Price Movement Reports - Newser
Has Sonoma Pharmaceuticals Inc. found a price floorAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - Newser
When is the best time to exit Sonoma Pharmaceuticals Inc.July 2025 Market Mood & Momentum Based Trading Ideas - Newser
Best data tools to analyze Sonoma Pharmaceuticals Inc. stock2025 Major Catalysts & High Yield Equity Trading Tips - Newser
How to build a dashboard for Sonoma Pharmaceuticals Inc. stockWeekly Profit Analysis & Safe Entry Zone Identification - Newser
Can swing trading help recover from Sonoma Pharmaceuticals Inc. lossesJuly 2025 Opening Moves & Advanced Technical Signal Analysis - Newser
Tick level data insight on Sonoma Pharmaceuticals Inc. volatilityJuly 2025 Spike Watch & Accurate Buy Signal Alerts - Newser
Long term hold vs stop loss in Sonoma Pharmaceuticals Inc.July 2025 PreEarnings & Verified Technical Trade Signals - Newser
Using data filters to optimize entry into Sonoma Pharmaceuticals Inc2025 Sector Review & Low Risk High Reward Ideas - Newser
Combining machine learning predictions for Sonoma Pharmaceuticals Inc.Trade Ideas & AI Driven Stock Reports - Newser
What’s the recovery path for long term holders of Sonoma Pharmaceuticals Inc.Market Activity Recap & Safe Entry Trade Reports - Newser
Is Sonoma Pharmaceuticals Inc. still worth holding after the dip2025 Major Catalysts & Accurate Technical Buy Alerts - Newser
Recovery Setup Building in Sonoma Pharmaceuticals Inc. Experts Say getLinesFromResByArray error: size == 0 - thegnnews.com
Using data filters to optimize entry into Sonoma Pharmaceuticals Inc.Market Risk Report & Real-Time Market Trend Scan - Newser
Comparing Sonoma Pharmaceuticals Inc. in custom built stock radarsWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Can technical indicators confirm Sonoma Pharmaceuticals Inc.’s reversal2025 Volume Leaders & Daily Price Action Insights - Newser
Sonoma Pharmaceuticals shareholders approve director election and other proposals - Investing.com India
What moving averages say about Sonoma Pharmaceuticals Inc.Bull Run & Technical Confirmation Trade Alerts - Newser
Pattern Scan Adds Sonoma Pharmaceuticals Inc. to Watchlist getLinesFromResByArray error: size == 0 - kangso.co.kr
Published on: 2025-08-30 15:44:38 - Newser
Visualizing Sonoma Pharmaceuticals Inc. stock with heatmapsRecession Risk & Precise Buy Zone Tips - Newser
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.60%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):